MSB 3.21% $1.13 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-291

  1. 6,361 Posts.
    lightbulb Created with Sketch. 379
    If Si & his experienced team felt that they needed legal representation they have the funds to choose that strategy.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.